APA (7th ed.) Citation

VAN DEN BOOGAARD, F. E., BRANDS, X., SCHULTZ, M. J., LEVI, M., ROELOFS, J. J. T. H., VAN 'T VEER, C., & VAN DER POLL, T. (2011). Recombinant human tissue factor pathway inhibitor exerts anticoagulant, anti‐inflammatory and antimicrobial effects in murine pneumococcal pneumonia. Journal of thrombosis and haemostasis, 9(1), 122-132. https://doi.org/10.1111/j.1538-7836.2010.04089.x

Chicago Style (17th ed.) Citation

VAN DEN BOOGAARD, F. E., X. BRANDS, M. J. SCHULTZ, M. LEVI, J. J. T. H. ROELOFS, C. VAN 'T VEER, and T. VAN DER POLL. "Recombinant Human Tissue Factor Pathway Inhibitor Exerts Anticoagulant, Anti‐inflammatory and Antimicrobial Effects in Murine Pneumococcal Pneumonia." Journal of Thrombosis and Haemostasis 9, no. 1 (2011): 122-132. https://doi.org/10.1111/j.1538-7836.2010.04089.x.

MLA (9th ed.) Citation

VAN DEN BOOGAARD, F. E., et al. "Recombinant Human Tissue Factor Pathway Inhibitor Exerts Anticoagulant, Anti‐inflammatory and Antimicrobial Effects in Murine Pneumococcal Pneumonia." Journal of Thrombosis and Haemostasis, vol. 9, no. 1, 2011, pp. 122-132, https://doi.org/10.1111/j.1538-7836.2010.04089.x.